Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3742951 B1
Tipo de publicaciónConcesión
Fecha de publicación23 Nov 1982
Fecha de presentación9 Ago 1971
Fecha de prioridad9 Ago 1971
Número de publicaciónUS 3742951 B1, US 3742951B1, US-B1-3742951, US3742951 B1, US3742951B1
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet

US 3742951 B1
Resumen  disponible en
Descripción  disponible en
Reclamaciones  disponible en
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US3886939 *4 Sep 19733 Jun 1975Steve BoxerDevice for alleviating muscular discomfort
US3896789 *10 Jun 197429 Jul 1975Riker Laboratories IncRetinoic acid dipensing pressure sensitive dermotological tape
US3948263 *14 Ago 19746 Abr 1976Minnesota Mining And Manufacturing CompanyBallistic animal implant
US3972995 *14 Abr 19753 Ago 1976American Home Products CorporationDosage form
US4039653 *21 Jul 19752 Ago 1977Defoney, Brenman, Mayes & BaronLong-acting articles for oral delivery and process
US4201211 *12 Jul 19776 May 1980Alza CorporationTherapeutic system for administering clonidine transdermally
US4289749 *9 Jul 198015 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing phenylpropanolamine
US4291014 *11 Jul 198022 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing estradiol diacetate
US4291015 *26 Jun 198022 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing a vasodilator
US4292301 *9 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ephedrine
US4292302 *9 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing terbutaline
US4292303 *9 Jul 198029 Sep 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing clonidine
US4294820 *9 Jul 198013 Oct 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing phenylephrine
US4314557 *19 May 19809 Feb 1982Alza CorporationDissolution controlled active agent dispenser
US4336243 *4 May 198122 Jun 1982G. D. Searle & Co.Transdermal nitroglycerin pad
US4420470 *8 Ene 198213 Dic 1983Nitto Electric Industrial Co., Ltd.Percutaneous absorption type pharmaceutical preparation of isosorbide dinitrate or pentaerythritol tetranitrate in pressure-sensitive laminate
US4421737 *25 Mar 198120 Dic 1983Nippon Kayaku Kabushiki KaishaPressure-sensitive adhesive tape or pressure-sensitive adhesive sheet containing nitroglycerin
US4455146 *2 Mar 198219 Jun 1984Hisamitsu Pharmaceutical Co., Ltd.Novel plasters
US4460368 *20 Ene 198317 Jul 1984Almedco, Inc.Trans-dermal medication system
US4460370 *16 Dic 198217 Jul 1984Almedco, Inc.Trans-dermal medication application cell
US4460562 *30 Mar 198317 Jul 1984Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US4482533 *28 Mar 198313 Nov 1984Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US4482534 *18 Ago 198313 Nov 1984Forest Laboratories, Inc.Nitroglycerin preparations
US4486193 *4 Feb 19834 Dic 1984Alza CorporationMethod for treating ischemic conditions by administering drug by two routes
US4556056 *9 Jun 19833 Dic 1985Max-Planck-Gesellschaft Zur Forderung Der/Wissenschaften E.V.Transparent fluid bandage material and the preparation and use thereof
US4563184 *17 Oct 19837 Ene 1986Bernard KorolSynthetic resin wound dressing and method of treatment using same
US4588580 *23 Jul 198413 May 1986Alza CorporationTransdermal administration of fentanyl and device therefor
US4594240 *7 Sep 198310 Jun 1986Teikoku Seiyaku Kabushiki KaishaSheet-shape adhesive preparation
US4597961 *23 Ene 19851 Jul 1986Etscorn Frank TTranscutaneous application of nicotine
US4605399 *4 Dic 198412 Ago 1986Complex, Inc.Transdermal infusion device
US4614787 *13 Nov 198430 Sep 1986Thermedics, Inc.Drug dispensing wound dressing
US4627852 *14 Dic 19849 Dic 1986Bayer AktiengesellschaftActive compound release systems
US4631227 *5 Dic 198323 Dic 1986Kenji NakamuraToilet article
US4638043 *23 Ago 198520 Ene 1987Thermedics, Inc.Drug release system
US4661104 *14 Dic 198428 Abr 1987Bayer AktiengesellschaftActive compound release systems
US4661105 *9 Jun 198628 Abr 1987Alza CorporationMedical bandage for administering vasodilator drug
US4666441 *17 Dic 198519 May 1987Ciba-Geigy CorporationMulticompartmentalized transdermal patches
US4680172 *5 Mar 198514 Jul 1987Ciba-Geigy CorporationDevices and methods for treating memory impairment
US4704119 *19 Nov 19863 Nov 1987Alza CorporationMethod comprising transdermal and buccal treatment of angina
US4704282 *29 Jun 19843 Nov 1987Alza CorporationTransdermal therapeutic system having improved delivery characteristics
US4725272 *29 Jun 198116 Feb 1988Alza CorporationNovel bandage for administering beneficial drug
US4725439 *13 Ene 198616 Feb 1988Alza CorporationTransdermal drug delivery device
US4727868 *20 May 19871 Mar 1988Thermedics, Inc.Anisotropic wound dressing
US4738670 *10 Jul 198719 Abr 1988Bayer AktiengesellschaftMedicinal plasters
US4743249 *10 Jun 198710 May 1988Ciba-Geigy Corp.Dermal and transdermal patches having a discontinuous pattern adhesive layer
US4749574 *1 Abr 19877 Jun 1988Fujisawa Pharmaceutical Co., Ltd.Sustained-release transdermal delivery preparations
US4751087 *19 Abr 198514 Jun 1988Riker Laboratories, Inc.Transdermal nitroglycerin delivery system
US4751133 *11 May 198714 Jun 1988Thermedics, Inc.Medical patches and processes for producing same
US4765985 *20 May 198723 Ago 1988Ciba-Geigy CorporationDevices and methods for treating memory impairment
US4767787 *24 Mar 198630 Ago 1988Kaken Pharmaceutical Co., Ltd.Sheet-shape adhesive preparation
US4776850 *12 May 198611 Oct 1988Beiersdorf AktiengesellschaftNitrate-containing plaster
US4787888 *1 Jun 198729 Nov 1988University Of ConnecticutDisposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US4812313 *14 Dic 198714 Mar 1989Alza CorporationMethod for lessening the incidence of anginal attacks
US4822617 *10 Abr 198718 Abr 1989Elan Corporation P.L.C.Drug delivery device
US4824676 *13 Feb 198725 Abr 1989Schering CorporationPhysiological means of enhancing transdermal delivery of drugs
US4830856 *27 Ene 198716 May 1989Peppers James MChelation product
US4834979 *14 Dic 198730 May 1989Alza CorporationMedical bandage for administering beneficial drug
US4836217 *23 Sep 19856 Jun 1989Fischer Torkel IHypersensitivity test means
US4839174 *5 Oct 198713 Jun 1989Pharmetrix CorporationNovel transdermal nicotine patch
US4844903 *6 Nov 19874 Jul 1989Mepha AgProcess for the production of an adhesive plaster
US4846826 *21 Nov 198611 Jul 1989Alza CorporationMethod for treating ischemic conditions
US4849226 *14 Dic 198718 Jul 1989Alza CorporationMethod for increasing oxygen supply by administering vasodilator
US4877618 *18 Mar 198831 Oct 1989Reed Jr Fred DTransdermal drug delivery device
US4879275 *27 May 19887 Nov 1989Nelson Research & Development Co.Penetration enhancers for transdermal delivery of systemic agent
US4880690 *9 Sep 198814 Nov 1989Thermedics, Inc.Perfume patch
US4889721 *15 Jul 198826 Dic 1989Fujisawa Pharmaceutical Co., Ltd.Sustained-release percutaneous preparations
US4898920 *15 Oct 19876 Feb 1990Dow Corning CorporationAdhesive compositions, controlled release compositions and transdermal delivery device
US4906475 *16 Feb 19886 Mar 1990Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4908027 *12 Sep 198613 Mar 1990Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US4917688 *27 Jun 198817 Abr 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US4920101 *30 Sep 198724 Abr 1990Nelson Research & Development Co.Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4938759 *2 Sep 19863 Jul 1990Alza CorporationTransdermal delivery device having a rate controlling adhesive
US4943435 *28 Oct 198824 Jul 1990Pharmetrix CorporationProlonged activity nicotine patch
US4954344 *10 Nov 19884 Sep 1990Alza CorporationMethod for treating nocturnal angina
US4959208 *28 Oct 198825 Sep 1990Ppg Industries, Inc.Active agent delivery device
US4969871 *15 Feb 198913 Nov 1990Alza CorporationIntravenous system for delivering a beneficial agent
US4973468 *22 Mar 198927 Nov 1990Cygnus Research CorporationSkin permeation enhancer compositions
US4985016 *15 Feb 198915 Ene 1991Alza CorporationIntravenous system for delivering a beneficial agent
US4997655 *22 Jun 19885 Mar 1991Biogal GyogyszergyarPharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
US5004610 *14 Jun 19902 Abr 1991Alza CorporationSubsaturated nicotine transdermal therapeutic system
US5008110 *10 Nov 198816 Abr 1991The Procter & Gamble CompanyStorage-stable transdermal patch
US5008111 *14 Dic 198816 Abr 1991Schering CorporationPhysiological means of enhancing transdermal delivery of drugs
US5034386 *17 Ago 198823 Jul 1991Whitby Research, Inc.Methods for administration using 1-substituted azacycloalkanes
US5035886 *10 May 199030 Jul 1991Ppg Industries, Inc.Active agent delivery device
US5035894 *8 Sep 198930 Jul 1991Dow Corning CorporationControlled release compositions and transdermal drug delivery device
US5045059 *15 Ago 19903 Sep 1991Alza CorporationIntravenous system for delivering a beneficial agent
US5053227 *12 Jun 19901 Oct 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5059189 *8 Sep 198722 Oct 1991E. R. Squibb & Sons, Inc.Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5059426 *12 Jun 199022 Oct 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5071645 *20 Mar 199110 Dic 1991Ppg Industries, Inc.Process of producing an active agent delivery device
US5088977 *21 Dic 198818 Feb 1992Drug Delivery Systems Inc.Electrical transdermal drug applicator with counteractor and method of drug delivery
US5091186 *15 Ago 198925 Feb 1992Cygnus Therapeutic SystemsBiphasic transdermal drug delivery device
US5147339 *19 Sep 199815 Sep 1992Coloplast A/SDressing material for the treatment of wounds, and corpuscles for use in the production thereof
US5151271 *24 Oct 198929 Sep 1992Nitti Electric Industrial Co., Ltd.Pressure-sensitively adhering composite medicinal preparation
US5160320 *14 Feb 19903 Nov 1992Alza CorporationIntravenous system for delivering a beneficial agent
US5173302 *28 Sep 199022 Dic 1992Medtronic, Inc.Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
US5186938 *7 Ago 199116 Feb 1993Key Pharmaceuticals, Inc.Adhesive transdermal dosage layer
US5204339 *6 Ago 199020 Abr 1993Whitby Research, Inc.Penetration enhancers for transdermal delivery of systemic agents
US5234690 *23 Ago 199110 Ago 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5250028 *9 Ago 19915 Oct 1993Alza CorporationIntravenous system for delivering a beneficial agent using permeability enhancers
US5268179 *14 Feb 19927 Dic 1993Ciba-Geigy CorporationUltrasonically sealed transdermal drug delivery systems
US5273755 *23 Ago 199128 Dic 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756 *23 Ago 199128 Dic 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5284660 *21 Ago 19928 Feb 1994Alza CorporationDelayed onset transdermal delivery device
US5328453 *12 Feb 199212 Jul 1994Drug Delivery Systems Inc.Method for enhancing transdermal drug delivery of electrical drug applicators
US5333621 *28 May 19932 Ago 1994Eric DenzerCondom with transdermal vasodilator
US5342623 *18 Jun 199330 Ago 1994Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US5402777 *3 Jun 19924 Abr 1995Alza CorporationMethods and devices for facilitated non-invasive oxygen monitoring
US5523094 *20 Jul 19944 Jun 1996SynthelaboTransdermal pharmaceutical composition
US5536263 *30 Mar 199416 Jul 1996Lectec CorporationNon-occulusive adhesive patch for applying medication to the skin
US5612382 *15 Jul 199418 Mar 1997Frances B. FikeComposition for percutaneous absorption of pharmaceutically active ingredients
US5613958 *6 Jun 199525 Mar 1997Pp Holdings Inc.Transdermal delivery systems for the modulated administration of drugs
US5633008 *12 Ago 199327 May 1997Osborne; James L.Method of administering nicotine transdermally
US5633009 *12 Nov 199327 May 1997Sano CorporationTransdermal administration of azapirones
US5643905 *10 Ene 19941 Jul 1997Therapie-System Gmbh & Co., KgPharmaceutical formulation for the treatment of nicotine dependence
US5668143 *3 Nov 199416 Sep 1997Merrell Pharmaceuticals Inc.Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
US5670164 *10 Ene 199423 Sep 1997Lts Lohmann Therapie-Systeme Bmgh & Co., KgNitroglycerin-containing patch, a process for the production and the use thereof
US5684017 *3 Nov 19944 Nov 1997Merrell Pharmaceuticals Inc.Benzenesulfonylimine derivatives as inhibitors of IL-1 action
US5728688 *7 Jun 199517 Mar 1998Endoreoherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5741510 *8 Abr 199621 Abr 1998Lectec CorporationAdhesive patch for applying analgesic medication to the skin
US5741511 *10 Abr 199621 Abr 1998Sam Yang Co., Ltd.Transdermal drug delivery device for treating erectile dysfunction
US5776923 *18 Ene 19947 Jul 1998Endorecherche, Inc.Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5780460 *7 Jun 199514 Jul 1998Endoreoherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5798347 *7 Jun 199525 Ago 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5807571 *7 Oct 199715 Sep 1998Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic systems for administering indole serotonin agonists
US5807849 *13 Jun 199515 Sep 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5817331 *7 Jun 19956 Oct 1998Sano CorporationTransdermal administration of azapirones
US5824671 *7 Jun 199520 Oct 1998Endorecherche IncTherapeutic methods and delivery systems utilizing sex steroid precursors
US5837280 *7 Jun 199517 Nov 1998Sano CorporationTransdermal administration of azapirones
US5837700 *7 Jun 199517 Nov 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5843932 *7 Jun 19951 Dic 1998Endorcaherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5854229 *7 Jun 199529 Dic 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5861170 *22 Mar 199419 Ene 1999Lts Lohmann Therapie-Systeme Gmbh & Co. KgAcetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
US5872114 *7 Jun 199516 Feb 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5912009 *29 Oct 199715 Jun 1999Theratech, Inc.Fatty acid esters of glycolic acid and its salts
US5922700 *7 Jun 199513 Jul 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5939095 *6 Dic 199417 Ago 1999Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman
US5948434 *7 Jun 19957 Sep 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5952000 *29 Oct 199714 Sep 1999Theratech, Inc.Fatty acid esters of lactic acid salts as permeation enhancers
US5955455 *13 Nov 199721 Sep 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US6007836 *19 May 199828 Dic 1999Vericade, Inc.Transdermal vasodilator
US6007837 *3 Feb 199928 Dic 1999Alza CorporationDrug delivery devices and process of manufacture
US6096333 *8 Oct 19971 Ago 2000Lectec CorporationMethod of forming adhesive patch for applying medication to the skin
US6096334 *14 Dic 19981 Ago 2000Lectec CorporationAdhesive patch for applying medication to the skin and method
US6165497 *1 Mar 199126 Dic 2000Alza CorporationSubsaturated nicotine transdermal therapeutic system
US61745453 Feb 199916 Ene 2001Alza CorporationDrug delivery devices and process of manufacture
US643294011 Jun 199913 Ago 2002Endorecherche, Inc.Uses for androst-5-ene-3β, 17β-diol
US6461596 *18 Feb 19978 Oct 2002Andrea TaylorComposition and method for promoting hair growth
US646544511 Jun 199815 Oct 2002Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US646922712 May 200022 Oct 2002Lectec CorporationAntipruritic patch
US65485108 Feb 200015 Abr 2003Lts Lohmann Therapie Systeme AgPharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence
US6627631 *8 Feb 200030 Sep 2003Lts Lohmann Therapie-Systeme AgPharmaceutical composition containing desoxypeganine for the treatment of alcoholism
US667034611 Jun 199930 Dic 2003Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US688479510 Jun 200226 Abr 2005Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US693332114 Feb 200323 Ago 2005Endorecherche, Inc.Antiandrogenic biphenyls
US696495510 Jun 200215 Nov 2005Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US699515010 Jun 20027 Feb 2006Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US701463018 Feb 200421 Mar 2006Oxyband Technologies, Inc.Tissue dressing having gas reservoir
US708764014 Mar 20038 Ago 2006Technology Commercialization CorpSubstance with sedative effect
US709442220 Ago 200322 Ago 2006Acrux Dds Pty Ltd.Topical delivery of antifungal agents
US716661726 Feb 200123 Ene 2007Mitsubishi Pharma CorporationCyclic amide derivatives
US726381415 Jul 20054 Sep 2007Oxyband Technologies, Inc.Method and apparatus for supplying gas to an area
US7393825 *11 Jun 20031 Jul 2008Strakan International LimitedMicrodose therapy
US742957630 Dic 200330 Sep 2008Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7678391 *6 Mar 200316 Mar 2010Queen's University At KingstonFormulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US78840923 Oct 20068 Feb 2011Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US79146453 Ene 200729 Mar 2011Dow Corning CorporationSilicone adhesive for adhesion to wet surfaces
US79436033 Oct 200617 May 2011Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US815316227 Sep 200610 Abr 2012Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US8168232 *25 Feb 20101 May 2012Queen's University At KingstonFormulations and methods of using nitric oxide mimetics in cancer treatment
US818284027 Sep 200622 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US818284127 Sep 200622 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US818763927 Sep 200629 May 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US81880663 Oct 200629 May 2012Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US820715918 Abr 200226 Jun 2012Hf Arzneimittelforschung GmbhUse of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances
US82362886 Ene 20127 Ago 2012Skinmedica, Inc.Melanin modification compositions and methods of use
US838954818 Feb 20055 Mar 2013Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US842012623 Abr 201216 Abr 2013Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US844023523 Abr 201214 May 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US845500923 Abr 20124 Jun 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US84607143 Abr 201211 Jun 2013Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US877831526 Feb 201315 Jul 2014Allergan, Inc.Melanin modification compositions and methods of use
US877838230 Abr 200415 Jul 2014Purdue Pharma L.P.Tamper resistant transdermal dosage form
US879068918 Nov 200529 Jul 2014Purdue Pharma L.P.Tamper resistant transdermal dosage form
US879641625 Oct 20115 Ago 2014Questcor Pharmaceuticals, IncACTH prophylactic treatment of renal disorders
US895721624 Mar 201117 Feb 2015Amitech Therapeutic Solutions, Inc.Heterocyclic compounds useful for kinase inhibition
US8992491 *13 Ene 201131 Mar 2015Laboratoires UrgoWound dressing including agglomerates of particles suitable for rapidly gelling or solubilizing
US904440426 Feb 20132 Jun 2015Allergan, Inc.Melanin modification compositions and methods of use
US90906517 Ene 200528 Jul 2015Endorecherche, Inc.Helix 12 directed pharmaceutical products
US916195412 Mar 201320 Oct 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US916195513 Mar 201320 Oct 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US916195613 Mar 201320 Oct 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US917506626 Abr 20103 Nov 2015Tissuetech, Inc.Compositions containing HC-HA complex and methods of use thereof
US919893913 Mar 20131 Dic 2015Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US921215112 Feb 201515 Dic 2015Amitech Therapeutic Solutions, Inc.Heterocyclic compounds useful for kinase inhibition
US92604177 Feb 201116 Feb 2016Amitech Therapeutic Solutions, Inc.Therapeutic methods and compositions involving allosteric kinase inhibition
US926574914 Abr 201523 Feb 2016Patara Pharma, LLCMethods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US927305114 Sep 20121 Mar 2016Pharmacyclics LlcPyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
US92843459 Abr 200815 Mar 2016Endorecherche, Inc.17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
US951211611 Oct 20136 Dic 2016Calcimedica, Inc.Compounds that modulate intracellular calcium
US952677027 Abr 201227 Dic 2016Tissuetech, Inc.Methods of modulating bone remodeling
US955082224 Jun 201424 Ene 2017Questcor Pharmaceuticals, Inc.ACTH prophylactic treatment of renal disorders
US96112637 Oct 20144 Abr 2017Calcimedica, Inc.Compounds that modulate intracellular calcium
US967573310 Nov 201613 Jun 2017Tissuetech, Inc.Methods of modulating bone remodeling
US96820448 Jun 201220 Jun 2017Tissuetech, Inc.Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US968296011 Dic 201420 Jun 2017Endorecherche, Inc.Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
US970052216 Dic 201411 Jul 2017Vita Sciences LlcTransdermal patch and method for delivery of vitamin B12
US97072069 Ago 201618 Jul 2017Patara Pharma, LLCMast cell stabilizers treatment for systemic disorders
US97243708 Sep 20158 Ago 2017Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US97441774 Mar 201529 Ago 2017Endorecherche, Inc.Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US97507718 Sep 20155 Sep 2017Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US97507729 Oct 20155 Sep 2017Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US975853323 Abr 201512 Sep 2017The Research Foundation For The State University Of New YorkRapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith
US98084913 Jun 20157 Nov 2017Tissuetech, Inc.Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
US20020187963 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187965 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187966 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187967 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187968 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
US20020187970 *10 Jun 200212 Dic 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
US20030181516 *14 Mar 200325 Sep 2003Krylov Boris VladimirovichSubstance with sedative effect
US20030212094 *26 Feb 200113 Nov 2003Haruko YamabeNovel cyclic amide derivatives
US20030215528 *6 Mar 200320 Nov 2003Queens University At KingstonFormulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20030220632 *21 May 200327 Nov 2003Wolfgang StrasserMethod of using gel sheets for laser treatment
US20040006134 *14 Feb 20038 Ene 2004Endorecherche, Inc.Antiandrogenic biphenyls
US20040081684 *20 Ago 200329 Abr 2004Monash UniversityTopical delivery of antifungal agents
US20040116406 *18 Abr 200217 Jun 2004Klaus OpitzUtilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
US20040132751 *18 Abr 20028 Jul 2004Klaus OpitzUse of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
US20040157812 *30 Dic 200312 Ago 2004Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20040167145 *5 Jul 200226 Ago 2004Klaus OpitzActive ingredient combination for the pharmacological therapy of nicotine dependence
US20040192683 *15 Jun 200230 Sep 2004Joachim MoormannActive ingredient combination for treating a dependence on addictive substances or narcotics using medicaments
US20040260253 *18 Feb 200423 Dic 2004Rosati Coni F.Method and apparatus for supplying gas to an area
US20050002997 *30 Abr 20046 Ene 2005Howard Stephen A.Tamper resistant transdermal dosage form
US20050053647 *16 Sep 200410 Mar 2005Rudolf MatuschPharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
US20050197300 *11 Jun 20038 Sep 2005Cellegy Pharmaceuticals Inc.Microdose therapy
US20050250749 *7 Ene 200510 Nov 2005Endorecherche, Inc.Helix 12 directed pharmaceutical products
US20050251084 *15 Jul 200510 Nov 2005Rosati Coni FMethod and apparatus for supplying gas to an area
US20060199866 *16 Abr 20047 Sep 2006Joachim MoormannCombination of desoxypeganine and mecamylanine for the treatment of alcohol abuse
US20060200100 *16 Feb 20067 Sep 2006Rosati Coni FMethod and apparatus for supplying gas to an area
US20070027122 *3 Oct 20061 Feb 2007Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20070027123 *3 Oct 20061 Feb 2007Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20070071828 *27 Sep 200629 Mar 2007Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US20070231401 *27 Sep 20064 Oct 2007Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US20080161277 *11 Abr 20073 Jul 2008Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20080295960 *3 Ene 20074 Dic 2008Schalau Ii Gerald KennethSilicone Adhesive For Adhesion To Wet Surfaces
US20080299087 *27 Sep 20064 Dic 2008Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US20090042844 *9 Abr 200812 Feb 2009Endorecherche, Inc.17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
US20090062781 *10 Nov 20085 Mar 2009Ed. Geistlich Soehne Ag Fur Chemische IndustrieMethod of using gel sheets for laser treatment
US20100068708 *7 May 200918 Mar 2010Wintherix LlcMethods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
US20100143270 *21 Feb 200810 Jun 2010University Of Louisville Research FoubdationTherapeutic cotinine compositions
US20100241219 *20 Jun 200623 Sep 2010Abbeymoor Medical , IncMedicament delivery article, accessory & system
US20100317635 *1 Jun 201016 Dic 2010Endorecherche, Inc.Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
US20110028543 *25 Feb 20103 Feb 2011Queens University At KingstonFormulations and methods of using nitric oxide mimetics in cancer treatment
US20130018335 *13 Ene 201117 Ene 2013Laboratoires UrgoNovel bandage including agglomerates of particles suitable for rapidly gelling or solubilising
USRE32991 *25 Jul 198818 Jul 1989Thermedics, Inc.Drug dispensing wound dressing
USRE3958831 Oct 199024 Abr 2007Alza CorporationTransdermal drug delivery device
DE2647581A1 *21 Oct 197627 Abr 1978Henkel KgaaBlisterpackung
DE3200369A1 *8 Ene 19825 Ago 1982Nitto Electric Ind CoPharmazeutisches praeparat
DE4301781A1 *23 Ene 199328 Jul 1994Lohmann Therapie Syst LtsNitroglycerinhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
DE102013107024A14 Jul 201315 May 2014Golden Biotechnology CorporationMethoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz
DE102013107025A14 Jul 20133 Jul 2014Golden Biotechnology CorporationMethoden und zusammensetzungen zur behanldung von diabetis
DE102013202928A122 Feb 201329 Ago 2013Golden Biotechnology CorporationVerfahren und Zusammensetzungen zum Behandeln von Krebsmetastasierung
EP0150426A2 *18 Dic 19847 Ago 1985Bayer AgDelivery system for an active substance
EP0150426A3 *18 Dic 198415 Ene 1986Bayer AgDelivery system for an active substance
EP0150428A2 *18 Dic 19847 Ago 1985Bayer AgDelivery system for an active substance
EP0150428A3 *18 Dic 198415 Ene 1986Bayer AgDelivery system for an active substance
EP0241806A1 *1 Abr 198721 Oct 1987Fujisawa Pharmaceutical Co., Ltd.Sustained-release transdermal delivery preparations
EP0273004A2 *16 Nov 198729 Jun 1988Ciba-Geigy AgUser-activated therapeutical system
EP0273004A3 *16 Nov 198713 Jul 1988Ciba-Geigy AgUser-activated therapeutical system
EP0301424A2 *22 Jul 19881 Feb 1989Fujisawa Pharmaceutical Co., Ltd.Sustained-release percutaneous preparations
EP0301424A3 *22 Jul 198812 Jul 1989Fujisawa Pharmaceutical Co., Ltd.Sustained-release percutaneous preparations
EP1674068A119 Feb 199728 Jun 2006Acrux DDS Pty LtdDermal penetration enhancers and drug delivery systems involving same
EP1731157A210 Jun 199913 Dic 2006Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
EP1749533A128 Oct 19987 Feb 2007Winthrop-University HospitalMetal/thiol biocides
EP2002826A113 Nov 200117 Dic 2008Euro-Celtique S.A.Titratable dosage transdermal delivery system
EP2087892A222 Jun 200012 Ago 2009Pharmacia & Upjohn Company LLC(S,S) reboxetine for treating age associated learning and mental disorders
EP2090312A122 Jun 200019 Ago 2009Pharmacia & Upjohn Company LLC(S,S) reboxetine for treating attention deficit disorder
EP2201840A128 Dic 200630 Jun 2010Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2386304A210 Jun 199916 Nov 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2386305A210 Jun 199916 Nov 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2399582A110 Jun 199928 Dic 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2443929A128 Dic 200625 Abr 2012Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2526771A128 Dic 200628 Nov 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526933A228 Dic 200628 Nov 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526934A228 Dic 200628 Nov 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529621A128 Dic 20065 Dic 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529622A128 Dic 20065 Dic 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2530083A128 Dic 20065 Dic 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532234A128 Dic 200612 Dic 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532235A128 Dic 200612 Dic 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2650294A112 Oct 201016 Oct 2013Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2664337A127 Sep 200620 Nov 2013TissueTech, Inc.Amniotic membrane preparations and purified compositions and methods of use
EP3178480A116 Jun 201014 Jun 2017Endorecherche, Inc.Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
WO1982000005A1 *26 Jun 19817 Ene 1982Key PharmaPolymeric diffusion matrix containing a vasodilator
WO1983000091A1 *8 Jul 198220 Ene 1983Keith, Alec, DellPolymeric diffusion matrix containing 5-ad(3,4-dimethoxyphenethyl)methylaminobd-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
WO1983000092A1 *8 Jul 198220 Ene 1983Key PharmaPolymeric diffusion matrix containing propranolol
WO1983000093A1 *8 Jul 198220 Ene 1983Key PharmaTrinitroglycerol sustained release vehicles and preparation therefrom
WO1987000042A1 *27 Jun 198615 Ene 1987Rutgers, The State University Of New JerseyTransdermal verapamil delivery device
WO1987001291A1 *28 Ago 198612 Mar 1987Rutgers, The State University Of New JerseyNovel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
WO1987001935A1 *1 Oct 19869 Abr 1987Rajadhyaksha Vithal JTransdermal and systemic preparation and method
WO1994026270A1 *25 Abr 199424 Nov 1994Lts Lohmann Therapie-Systeme Gmbh & Co. KgTransdermal therapeutic systems for the administration of serotonin agonists
WO1994027536A1 *20 May 19948 Dic 1994Vericade, Inc.Condom with transdermal vasodilator
WO2004075933A2 *26 Feb 200410 Sep 2004Lavipharm S.A.Devices for releasing volatile substances and methods of producing the devices
WO2004075933A3 *26 Feb 200413 Ene 2005Lavipharm SaDevices for releasing volatile substances and methods of producing the devices
WO2005066194A16 Ene 200521 Jul 2005Endorecherche, Inc.Helix 12 directed steroidal pharmaceutical products
WO2007062266A228 Nov 200631 May 2007Marinus PharmaceuticalsGanaxolone formulations and methods for the making and use thereof
WO2007084266A2 *3 Ene 200726 Jul 2007Dow Corning CorporationSilicone adhesive for adhesion to wet surfaces
WO2007084266A3 *3 Ene 200729 Nov 2007Dow CorningSilicone adhesive for adhesion to wet surfaces
WO2008021368A213 Ago 200721 Feb 2008The Johns Hopkins UniversityCompositions and methods for neuroprotection
WO2008039218A228 Dic 20063 Abr 2008Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
WO2008066899A228 Nov 20075 Jun 2008Marinus PharmaceuticalsNanoparticulate formulations and methods for the making and use thereof
WO2008109124A1 *6 Mar 200812 Sep 2008Novalar Pharmaceuticals, Inc.Use of nitroglycerin to reverse local anesthesia
WO2008124922A111 Abr 200823 Oct 2008Endorecherche, Inc.17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
WO2010071866A219 Dic 200924 Jun 2010Nuon Therapeutics, Inc.Combination therapy for arthritis with tranilast
WO2011119894A224 Mar 201129 Sep 2011Kinagen, IncHeterocyclic compounds useful for kinase inhibition
WO2011130689A115 Abr 201120 Oct 2011Tracon Pharmaceuticals, Inc.Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
WO2011139489A211 Abr 201110 Nov 2011Calcimedica Inc.Compounds that modulate intracellular calcium
WO2014130619A220 Feb 201428 Ago 2014Golden Biotechnology CorporationMethods and compositions for treating leukemia
WO2015084998A13 Dic 201411 Jun 2015Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
WO2017027402A15 Ago 201616 Feb 2017Patara Pharma, LLCMethods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
WO2017040617A131 Ago 20169 Mar 2017Pharmacyclics LlcBtk inhibitor combinations for treating multiple myeloma
Clasificaciones
Clasificación internacionalA61K9/70
Clasificación cooperativaA61K9/7092, A61K9/7061, A61K9/7084
Clasificación europeaA61K9/70E2B6B2, A61K9/70E2D, A61K9/70E2K
Eventos legales
FechaCódigoEventoDescripción
23 Nov 1982B1Reexamination certificate first reexamination